3326 - 3350 of 9038 Results
Title
Year
- Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression2020OPENTitle: Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1466End Page: 1471Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28073Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28073Citation Count: 30
- Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy2019RESTRICTEDTitle: Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergyJournal Name: The Journal of Allergy and Clinical Immunology: In PracticePublisher: Elsevier BVVol: 8Issue #: 2Start Page: 780End Page: 782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jaip.2019.07.040Citation Count: 1
-
OPENTitle: Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorderJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 9Start Page: e70570End Page: e70570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70570Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12447249Citation Count: 2
-
OPENTitle: A Biomarker‐Based Classification of Corticobasal SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 1Start Page: 129End Page: 142Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.70070Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70070Citation Count: 5
-
OPENTitle: Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse TissuesJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2344End Page: 2344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112344Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2344/pdf?version=1603442755Citation Count: 60
-
OPENTitle: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microgliaJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 121End Page: 137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385752Citation Count: 55
-
OPENTitle: Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 4Start Page: 357End Page: 367Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00029-3Best OA location URL: https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(26)00029-3.pdfCitation Count: 4
-
OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 25
- Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)2018OPENTitle: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 9Start Page: 793End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nly056Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/9/793/25507335/nly056.pdfCitation Count: 37
-
OPENTitle: Small Molecule Improvement of Trafficking Defects in Models of NeurodegenerationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 21Start Page: 3972End Page: 3984Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9754116Citation Count: 1
- Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants2024RESTRICTEDTitle: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 126Issue #:Start Page: 107041End Page: 107041Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041Citation Count: 0
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 12Start Page: 2688End Page: 2699Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 4
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6261681Citation Count: 21
- LRRK2 variation and Parkinson's disease in African Americans2010RESTRICTEDTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Citation Count: 14
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease ResearchJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 4Start Page: 972End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70183Citation Count: 0
- Early Detection of Parkinson's Disease Using an Ensemble Framework QuadFusionNet with Deep Learning and Explainable AI2025RESTRICTEDTitle: Early Detection of Parkinson's Disease Using an Ensemble Framework QuadFusionNet with Deep Learning and Explainable AIJournal Name: 2025 International Conference on Modeling, Simulation & Intelligent Computing (MoSICom)Publisher: IEEEVol:Issue #:Start Page: 316End Page: 321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/mosicom67153.2025.11398248Citation Count: 0
-
OPENTitle: Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammationJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 132Issue #:Start Page: 106217End Page: 106217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbi.2025.106217Best OA location URL: https://doi.org/10.1016/j.bbi.2025.106217Citation Count: 2
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 128
-
OPENTitle: Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient StimuliJournal Name: NeuronPublisher: Elsevier BVVol: 94Issue #: 6Start Page: 1205End Page: 1219.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.05.020Best OA location URL: http://www.cell.com/article/S0896627317304580/pdfCitation Count: 283
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
-
OPENTitle: Subspace corrected relevance learning with application in neuroimagingJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 149Issue #:Start Page: 102786End Page: 102786Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.artmed.2024.102786Best OA location URL: https://doi.org/10.1016/j.artmed.2024.102786Citation Count: 8
-
OPENTitle: Cadherin‐8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuitsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 523Issue #: 1Start Page: 75End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23666Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4232472Citation Count: 59
-
OPENTitle: Dying-back of ascending noradrenergic projections in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2562End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab286Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2562/40880422/awab286.pdfCitation Count: 7
- Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients2017RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 175